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Mutant proteins (muteins) of human Interleukinl (IL4) weee constructed by means of in vitro mutagenesis. The muteins were expressed in E. cofi, 
submitted to a renaturation and purification protocol and analysed for biological activity. Exchange of the cysteines at either position 46 or 99 
which form one of the three disulfide bridges resulted in a nearly cc’mplete loss of biological activity and an unstable protein. The exchange of 
tyrosine 124 also inactivated the protein, while a mutation of tyrosine 56 left some residual activity. Exchange of the other four cysteines or of 
the single tryptophane had smaller effects. 
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1. INTRODUCTION 
Interleukin-4 (IL4) is one of the many cytokines 
which induce and coordinate the proliferation, matura- 
tion, survival and differentiation of lymphoid and 
myeloid cells (for reviews ee [l-3]). In particular, IL4 
functions in IgE-mediated immune responses, and pro- 
motes directly the proliferation of thymocytes and ac- 
tivated T-cells. A high affinity IL4 receptor protein of 
W 140 000 has been identified, which consists of 800 
amino acid residues according to the cDNA sequence 
[4]. It belongs to a recently described group of recep- 
tors, designated as hematopoietin receptor superfamily 
PI. 
The amino acid sequence of mature human IL4 as 
deduced from the cloned cDNA [6] consists of 129 
residues. The cDNA has been expressed in E. coli [7,8] 
and yeast 191. From these sources recombinant IL4 with 
high biological activity has been prepared. Circular 
dichroism and protein-chemical experiments with 
mouse and human IL4 have been reported that revealed 
some properties of the aromatic amino acid residues 
[IO, 121 as we1 as the pairing of the six cysteines in three 
disulfide bridges [l 1,131. In the present study the same 
amino acid residues of human IL4 were exchanged by in 
vitro mutagenesis in order to analyse their significance 
for structure and function of the protein, 
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2. MATERIALS AND METHODS 
An EcoRV/BamHI fragment encoding the major part of mature 
human Interleukin4 was excised from an engineered cDNA (British 
Bio-technology Ltd., Oxford, England). This DNA fragment together 
with synthetic oligonucleotides 5’-CATGCACAAGTCCGAT and 
5’-ATCGCACTTGTG, comprising the first 4 amino acid codons of 
Interleukin-4 plus the codon for methionine, were integrated between 
the Me01 and BanrHl sites of expression vector R’rSpRC109 [14]. 
Oligonucleotide-directed mutagenesis was performed by the gapped 
duplex DNA approach [14,15]. The final construct of the mutated 
cDNA was sequenced and after confirmation of the specific change 
the strain was used for expression of the mutant protein. 
Recombinant human Interleukin-4 (rhII.4) and IL4 muteins were 
isolated essentially as described by Kato et al. [16] with modifications 
detailed elsewhere [14]. All fractions obtained after CM-Sepharose 
chromatography and after HPLC were analysed by dodecylsulfate 
polyacrylamide-gel electrophoresis 1171. Protein concentration was 
determined by absorbance at 280 nm (1 mg IL4/ml was assumed to 
yield an absorbance at 280 nm of 1). Proper corrections were made in 
the case of variants missing tryptophane or tyrosine [IS]. 
The amount of IL4 in the ‘inclusion body’ fraction was estimatc:l 
by co-electrophoresis of these fractions and defined amounts of pure 
rhIL4 and subsequent densitometric determination of bound 
Coomassie blue stain. Proliferative activities were determined by 
measuring in duplicate the IL4-dependent incorporation of 
[‘Hlthymidine into peripheral blood lymphocytes preactivated for 7 
days with phytohemagglutinine [6]. 
3. RESULTS AND DISCUSSION 
The rhIL4 protein is expressed with reasonable ffi- 
ciency (15-20% of whole cell protein; Fig. 1A) in the 
constructed E. cd strains employing the right pro- 
motor of phage lambda and temperature-sensitive 
lambda repressor together with the ribosome binding 
site of the E. coli atpE cistron [19], Comparable results 
are obtained when the same ribosome binding site is 
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subsitution of the cysteines at either position 46 or 99 by 
threonine rendered the protein unstable. Pro!iferative 
activity with C46T and C99T was less than 1070 of wild- 
type activity (Fig. 2). Replacement of cysteines in C3T, 
C24T, C65T and C127T reduced the biological activity 
to some extent. Specific activities 3-5 times lower than 
in the normal IL4 were measured. The six cysteine 
residues in rhIL4 have been assigned to three disulfide 
bridges [ll, 131. Most interestingly, the cysteines at 
positions 46 and 99 form one disulfide bridge which ac- 
cording to the results above is essential for structure and 
function. The disulfide bridges formed between cys- 
teines 3 and 127 as well as between cysteines 24 and 65 
seem to be less important for structural integrity. 
“Inclusion bodies’ from IL4 wild-type and mutant 
strains could be assayed directly for biological activity 
by diluting solutions of proteins denaturated in 
guanidiniumchloride or dodecylsulfate buffers into the 
T-cell culture medium (RPMI/lO% fetal calf serum). 
Specific activities were measured in the order IL4 wild- 
type > C3T - C24T - C65T - C 127T > C46T - C99T. 
These are the same relations as found with the purified 
proteins (Fig. 2), even though the absolute values were 
about 20-fold (guanidiniumchloride buffer) or loo-fold 
(dodecylsulfate buffer) lower. 
Fig. 1. Purification of recombinant human Interleukin-4 from an 
overproducing E. colistrain. Whole cellular proteins [a], soluble pro- 
teins [b], inclusion bodies [cl, combined fractions after CM- 
Sepharose chromatography [d] and after HPLC [e] were submitted to 
dodecylsulfate-gel electrophoresis and visualized by staining with 
Coomassie brilliant blue R-250. 
used together with a synthetic promotor from phage T5 
and the operatur/repressor system from the lac operan 
[20]. As demonstrated in Fig. 1C the recombinant pro- 
tein is concentrated in the particulate fraction of the E. 
coli homogenate (60~80% of total protein). Compared 
to sedimented ‘inclusion bodies’ of other recombinant 
cytokines, e,g. of IL2 [ 141, the IL4-containing sediment 
exhibited a more fluffy and greenish appearance. After 
renaturation of the 6 M-guanidiniumchloride-dissolved 
protein the rhIL4 was eluted at 0.35-0.4 M NaCl from 
the CM-Sepharose column recovering 20-30% of IL4 
present in the ‘inclusion bodies’. During HPLC over a 
C4 column the rhIL4 eluted at 40-42070 acetonitrile. The 
final yield was 1-2 mg IL4 per 1 of original E. coli 
culture with a purity better than 95%. The specific 
biological activity as measured by the halfmaximal pro- 
liferative response of human T-cells amounted to 
0.2-0.5 X 10G U/mg protein, 
The six cysteine codons in the IL4 cDNA have been 
singly replaced by a threonine codon in order to pro- 
duce muteins C3T, C24T, C46T, C65T, C99T and 
C127T. The side chain of threonine has a surface area 
only slightly larger than that of cysteine [21], Each of 
the six mutant protcifis could be isolated and purified, 
In the case of C46T very low yields were observed. 
Re-analysis of the purified variants by HPLC reveal- 
ed multiple species with C46T and C9K. Apparently, 
Recently, biophysical and protein-chemical studies 
on the aromatic side chains of human IL4 have been 
reported [lo, 121. We have singly replaced the two 
tyrosines by aspartic acid and the tryptophane by 
arginine, yielding the muteins YSGD, 124D ana W91R. 
Despite these drastic changes affecting size, polarity 
and charge of the particular side chains, these three mu- 
teins could be purified in yields comparable to wild-type 
IL4. Replacing the aromatic side chains lead to the ex- 
pected changes of the absorbance spectrum in the near 
UV. During re-analysis by HPLC all three muteins were 
eluted as single peaks at an unchanged acetonitrile con- 
centration. This suggests that the structure was not im- 
paired to a major extent by these amino acid exchanges. 
Interestingly, W9lR showed an unchanged or even 
moderately enhanced specific proliferative activity (Fig. 
2). According to circular dichroism measurements the 
tryptophane is largely accessible to the solvent [12]. It is 
also easily modified by N-bromosuccinimide [IO]. In 
mouse IL4 the position of tryptophane 91 appears to be 
also occupied by an arginine [I 11, Thus it is conceivable 
that the human IL4 mutein W9lR exhibits full 
biological activity. It has to be noted, however, that 
chemical modification reduces biological activity [lo]. 
The Y124D mutein was completely inactive, while 
Y56D retained 5-10‘70 of the wild-type activity. 
Tyrosine 124 but not tyrosine 56 is easily modified by 
tetranitromcthane [lo]. Accordingly, tyrosine 124 is 
probably exposed at the protein surface. The activity is 
only marginally reduced by this chemical modification. 
Both tyrosines are conserved between human and 
mouse IL4. Mutein Y 124D where tyrosine 124 is 
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Purified Interlcukin-4 proteins 
Fig. 2. Specific proliferative activities (U/mg protein) of purified Interleukin-4.wild-type (WT) and mutant proteins. Three independent samples 
of each protein were assayed in duplicate. Standard deviations are indicated by bars. The abbreviations of the purified lL4 protein-wild type (WT) 
and muteins are defined in the text. The activity of the Y 124D protein could not be determined (n.d.): even at 1 pg/ml no [‘Hlthymidine incorpora- 
tion could be measured. 
substituted by an acidic side chain seems to be struc- 
turally intact as it eluted as a single peak during HPLC. 
Thus, the functional impairment observed after muta- 
tion of this side chain suggests a direct functional role 
of tyrosine 124 in receptor binding. The chemically in- 
active and therefore possibly internal residue tyrosine 
56 is less likely to be involved in receptor binding. Thus, 
its substitution by aspartic acid possibly disturbed the 
folding of the protein with a concomitant loss in 
biological activity. This of course has to be established 
by a more thorough comparison of the conformation of 
wild-type and mutant proteins. 
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